Evidence map›Paper›PMID 35027450›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Ribosomally derived lipopeptides containing distinct fatty acyl moieties.

Florian Hubrich, Nina M Bösch, Clara Chepkirui, Brandon I Morinaka, Michael Rust, Muriel Gugger, Serina L Robinson, Anna L Vagstad, Jörn Piel

Erratum issuedAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Exploring RiPP-derivedRSC chemical biology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Structure, biosynthesis, and bioactivity of nostolysamides.bioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Article
  9. Peptide Prenylation Follows Divergent Substrate Engagement Rules.Journal of the American Chemical Society · 2025
    Article
  10. Article
  11. Article
  12. Sterically Controlled C(spOrganic letters · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Florian HubrichInstitute of Microbiology, Eidgenössische Technische Hochschule (ETH) Zürich, 8093 Zürich, Switzerland.ORCID 0000-0001-7093-8123
Nina M BöschInstitute of Microbiology, Eidgenössische Technische Hochschule (ETH) Zürich, 8093 Zürich, Switzerland.ORCID 0000-0001-6656-7040
Clara ChepkiruiInstitute of Microbiology, Eidgenössische Technische Hochschule (ETH) Zürich, 8093 Zürich, Switzerland.
Brandon I MorinakaInstitute of Microbiology, Eidgenössische Technische Hochschule (ETH) Zürich, 8093 Zürich, Switzerland.
Michael RustInstitute of Microbiology, Eidgenössische Technische Hochschule (ETH) Zürich, 8093 Zürich, Switzerland.ORCID 0000-0001-6648-2434
Muriel GuggerCollection of Cyanobacteria, Institut Pasteur, 75724 Paris, France.
Serina L RobinsonInstitute of Microbiology, Eidgenössische Technische Hochschule (ETH) Zürich, 8093 Zürich, Switzerland.ORCID 0000-0001-6947-7913
Anna L VagstadInstitute of Microbiology, Eidgenössische Technische Hochschule (ETH) Zürich, 8093 Zürich, Switzerland; avagstad@ethz.ch jpiel@ethz.ch.ORCID 0000-0001-8074-0137
Jörn PielInstitute of Microbiology, Eidgenössische Technische Hochschule (ETH) Zürich, 8093 Zürich, Switzerland; avagstad@ethz.ch jpiel@ethz.ch.ORCID 0000-0002-2282-8154

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipopeptides represent a large group of microbial natural products that include important antibacterial and antifungal drugs and some of the most-powerful known biosurfactants. The vast majority of lipopeptides comprise cyclic peptide backbones N-terminally equipped with various fatty acyl moieties. The known compounds of this type are biosynthesized by nonribosomal peptide synthetases, giant enzyme complexes that assemble their products in a non-gene-encoded manner. Here, we report the genome-guided discovery of ribosomally derived, fatty-acylated lipopeptides, termed selidamides. Heterologous reconstitution of three pathways, two from cyanobacteria and one from an arctic, ocean-derived alphaproteobacterium, allowed structural characterization of the probable natural products and suggest that selidamides are widespread over various bacterial phyla. The identified representatives feature cyclic peptide moieties and fatty acyl units attached to (hydroxy)ornithine or lysine side chains by maturases of the GCN5-related

Indexed as

Anti-Bacterial AgentsAntifungal AgentsBiosynthetic PathwaysCyanobacteriaLipopeptidesPeptides, CyclicPeptide SynthasesRibosomesAnti-Bacterial AgentsAntifungal AgentsLipopeptidesnon-ribosomal peptide synthasePeptides, CyclicPeptide SynthasesbiosynthesisN-acylationnatural productspeptidesRiPPs

Identifiers

PMID35027450
PMCPMC8784127

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.